Publication | Closed Access

Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia

Metabolic SyndromeLipid DisorderApolipoprotein ECardiovascular DiseaseDiabetesGenetic EpidemiologyBaseline Lipid LevelsHuman PolymorphismHyperlipidemiaDyslipidemiaLipid ResponseLipoprotein MetabolismPublic HealthMedicineAtherosclerosisEpidemiology